286 related articles for article (PubMed ID: 25550217)
1. Polymer-based nanocarriers for vaginal drug delivery.
das Neves J; Nunes R; Machado A; Sarmento B
Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
[TBL] [Abstract][Full Text] [Related]
2. Recent advances on anti-HIV vaginal delivery systems development.
Antimisiaris SG; Mourtas S
Adv Drug Deliv Rev; 2015 Sep; 92():123-45. PubMed ID: 25858666
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy.
Woodsong C; Holt JD
Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190
[TBL] [Abstract][Full Text] [Related]
4. New strategies for local treatment of vaginal infections.
Palmeira-de-Oliveira R; Palmeira-de-Oliveira A; Martinez-de-Oliveira J
Adv Drug Deliv Rev; 2015 Sep; 92():105-22. PubMed ID: 26144995
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive and thermogelling systems for vaginal drug delivery.
Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
[TBL] [Abstract][Full Text] [Related]
6. Special issue on vaginal drug delivery.
de Oliveira RP; de Oliveira JM; Caramella C
Adv Drug Deliv Rev; 2015 Sep; 92():1. PubMed ID: 26452325
[No Abstract] [Full Text] [Related]
7. Vaginal drug distribution modeling.
Katz DF; Yuan A; Gao Y
Adv Drug Deliv Rev; 2015 Sep; 92():2-13. PubMed ID: 25933938
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based vaginal drug delivery systems for HIV prevention.
Mallipeddi R; Rohan LC
Expert Opin Drug Deliv; 2010 Jan; 7(1):37-48. PubMed ID: 20017659
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves J; Amiji M; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
[TBL] [Abstract][Full Text] [Related]
10. Vaginal microbicides: moving ahead after an unexpected setback.
van de Wijgert JH; Shattock RJ
AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
[No Abstract] [Full Text] [Related]
11. In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine.
das Neves J; Araújo F; Andrade F; Michiels J; Ariën KK; Vanham G; Amiji M; Bahia MF; Sarmento B
Mol Pharm; 2013 Jul; 10(7):2793-807. PubMed ID: 23738946
[TBL] [Abstract][Full Text] [Related]
12. Nano-sized platforms for vaginal drug delivery.
El-Hammadi MM; Arias JL
Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
Joanis CL; Hart CW
AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
[TBL] [Abstract][Full Text] [Related]
16. Vaginal films for drug delivery.
Machado RM; Palmeira-de-Oliveira A; Martinez-De-Oliveira J; Palmeira-de-Oliveira R
J Pharm Sci; 2013 Jul; 102(7):2069-81. PubMed ID: 23649325
[TBL] [Abstract][Full Text] [Related]
17. Preclinical assessments of vaginal microbicide candidate safety and efficacy.
Fernández-Romero JA; Teleshova N; Zydowsky TM; Robbiani M
Adv Drug Deliv Rev; 2015 Sep; 92():27-38. PubMed ID: 25543007
[TBL] [Abstract][Full Text] [Related]
18. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
19. Current and future microbicide approaches aimed at preventing HIV infection in women.
Pozzetto B; Delézay O; Brunon-Gagneux A; Hamzeh-Cognasse H; Lucht F; Bourlet T
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):167-83. PubMed ID: 22339191
[TBL] [Abstract][Full Text] [Related]
20. Will vaginal microbicides solve the HIV problem in Africa?
Muula AS
Croat Med J; 2006 Dec; 47(6):895-8. PubMed ID: 17167863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
